Atorvastatin and glatiramer acetate: new hope in MS?
Bradbury
Jane
J
D000276:Adjuvants, Immunologic / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000069059:Atorvastatin; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D000068717:Glatiramer Acetate; D006538:Heptanoic Acids / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy; D007249:Inflammation; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010455:Peptides / Q000494:pharmacology / Q000627:therapeutic use*; D011758:Pyrroles / Q000494:pharmacology / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D010455:Peptides; D011758:Pyrroles; D000068717:Glatiramer Acetate; D000069059:Atorvastatin